An interventional study of Live teleconference supervision and Taped Review Supervision in Substance Abuse, sponsored by New York State Psychiatric Institute. Completed at 1 site in United States. Open to participants aged 18 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-12-26.
Sponsored by New York State Psychiatric Institute · Not applicable, Interventional, and Health services research
This study aims to train Substance Abuse Treatment Clinicians in the use of Motivational Interviewing techniques through live supervision.
New evidence-based treatments have been slow to be adopted into the routine practice of addiction treatment, and traditional training methods are of limited effectiveness. In this study, the investigators propose to continue development of methods for training clinicians in Motivational Interviewing (MI), based on the principle of live supervision. Live supervision (supervisor and trainee seeing a patient together) is common in basic training, but rarely used in continuing education. In the initial funding period we developed Teleconference Supervision (TCS), which implements live supervision by an expert through teleconferencing technology, harnessing the principles of context-dependent learning, differential reinforcement with immediacy of feedback, and modeling. Clinicians interview standard patients at their home clinics, while Supervisors listen via telephone. The clinician wears an earpiece, through which the Supervisor provides immediate feedback and coaching designed to differentially reinforce and shape MI skills. In a randomized controlled trial with community clinicians (N= 100), TCS produced superior overall MI skill, compared to control conditions where clinicians received Workshop only training, or standard tape-based supervision. Findings were encouraging yet the proportion of clinicians achieving expert proficiency was limited, and there were trends toward loss of skill at follow-up, suggesting longer training is needed to maximize and sustain MI skill.
In the new funding period, the investigators propose to build and improve upon TCS by testing an extended model of Teleconference Supervision (TCS-Plus), which will preserve the elements of live supervision from an expert supervisor but will also provide 4 sessions of enhanced tape review supervision on a bi-weekly basis after the initial TCS training. Using telephone technology, enhanced taped review allows the Supervisor and Clinician to listen to the taped session together before discussing the session. Practice sessions will increase from 5 to 9 and be spread out from 8 to 16 weeks. Providing both TCS and enhanced tape review supervision maximizes supervision style advantages. While both offer context dependent learning, TCS provides for modeling and differential reinforcement with immediacy of feedback, and enhanced tape review provides ample time to role play and discuss technique. TCS-Plus will be compared to standard Tape Review supervision. The proposed project will be a StageI trial, intent on maximizing the gains already detected with the TCS model. The investiators will assess if TCS-Plus produces superior MI skill to standard Tape Review supervision in a randomized trial with 130 community based-clinicians. It is hoped that, if successful, TCS-Plus could be a model for remote training and supervision at community treatment programs, promoting adoption of a variety of evidence-based treatments for substance use disorders into routine practice.
2,124 studies on the registry are indexed under Substance-Related Disorders; 393 are open to participants now.
This study's enrollment of 91 is below the median of 108 across 1,727 interventional studies indexed under Substance-Related Disorders.
Browse Substance-Related Disorders studies →New York State Psychiatric Institute is the lead sponsor of 425 studies on the registry; 26 are open to participants now.
Of its 50 completed or terminated interventional studies of FDA-regulated products, 45 (90%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Clinicians from participating substance abuse treatment programs receive live supervision by MI trainer via teleconference while in session with client.
Behavioral: Live teleconference supervision
Clinicians from participating substance treatment programs audio record session with client and receive supervision after the session by MI trainer.
Behavioral: Taped Review Supervision
Participants receive live teleconference supervision during a session with a client on their use of Motivational Interviewing (MI) in the session. MI is a directive, client-centered counseling style for eliciting behavior change by helping clients to explore and resolve ambivalence. Compared with nondirective counselling, it is more focused and goal-directed. The examination and resolution of ambivalence is its central purpose, and the counselor is intentionally directive in pursuing this goal.
Also known as: Motivational Enhancement Therapy, MI, MET
Participants audio record a session with a client and receive supervision after the session on their use of Motivational Interviewing during the session.
Number of Participants With MI Skillfulness
MI skillfulness measured by the Motivational Interviewing Treatment Integrity Scale (MITI) on double coded audio recorded sessions and clinical interviews. The cumulative number of participants with MI Skillfulness at each time point assessed at 1, 8, 16, 24, and 32 weeks are reported.
Time frame: 1,8,16, 24 and 32 weeks
| Milestone | Live Teleconference Supervision | Taped Review Supervision |
|---|---|---|
| Started | 48 | 43 |
| Completed | 48 | 43 |
| Not completed | 0 | 0 |
MI skillfulness measured by the Motivational Interviewing Treatment Integrity Scale (MITI) on double coded audio recorded sessions and clinical interviews. The cumulative number of participants with MI Skillfulness at each time point assessed at 1, 8, 16, 24, and 32 weeks are reported.
| Participants | Live Teleconference Supervision | Taped Review Supervision |
|---|---|---|
| Number of Participants With MI Skillfulness | 48 | 43 |
Collected over From consent through completion of trial, an average of 4 weeks.. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Live Teleconference Supervision | 0/48 (0%) | 0/48 (0%) | 0/48 (0%) |
| Taped Review Supervision | 0/43 (0%) | 0/43 (0%) | 0/43 (0%) |
| Age, Categorical(Participants) | Live Teleconference Supervision | Taped Review Supervision | Total |
|---|---|---|---|
| <=18 years | 0 | 0 | 0 |
| Between 18 and 65 years | 48 | 43 | 91 |
| >=65 years | 0 | 0 | 0 |
| Sex: Female, Male(Participants) | Live Teleconference Supervision | Taped Review Supervision | Total |
|---|---|---|---|
| Female | 29 | 20 | 49 |
| Male | 19 | 23 | 42 |
| Race/Ethnicity, Customized(Participants) | Live Teleconference Supervision | Taped Review Supervision | Total |
|---|---|---|---|
| Race/Ethnicity — White, not Hispanic | 12 | 11 | 23 |
| Race/Ethnicity — Black, not Hispanic | 24 | 14 | 38 |
| Race/Ethnicity — Hispanic | 12 | 15 | 27 |
| Race/Ethnicity — Asian or Pacific Islander | 0 | 2 | 2 |
| Race/Ethnicity — American Indian or Native American | 0 | 0 | 0 |
| Race/Ethnicity — Other | 0 | 1 | 1 |
| Region of Enrollment(Participants) | Live Teleconference Supervision | Taped Review Supervision | Total |
|---|---|---|---|
| United States | 48 | 43 | 91 |
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Dec 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
New York State Psychiatric Institute